A U.S. Patent for a “Method of Using Human FC-Bearing IGG Antibodies to Polyethylene Glycol” was awarded to Bristol-Myers Squibb on October 22nd, 2019.  The present invention is a method of detecting human IgG anti-polyethylene glycol (PEG) antibodies in a sample from a human subject comprising: a. exposing a PEG-coated surface to a sample from a human subject, wherein the sample is blood, serum or any other blood fraction; b. washing the PEG-coated surface; c. detecting the presence or absence of human IgG anti-PEG antibodies bound to the PEG-coated surface; and d. determining the presence… Learn More